ATOSSA GENETICS INC. DEALER-MANAGER AGREEMENTDealer-Manager Agreement • April 23rd, 2018 • Atossa Genetics Inc • Pharmaceutical preparations • New York
The following will confirm our agreement relating to the proposed rights offering (the “Rights Offering”) to be undertaken by Atossa Genetics Inc., a Delaware corporation (the “Company”), pursuant to which the Company will distribute to holders of record of its common stock, par value $0.18 per share (the “Common Stock”) and holders of warrants issued December 22, 2017, subscription rights (the “Rights”) to subscribe for up to an aggregate of 20,000 units (the “Units”), each Unit consisting of one share of Preferred Stock (the “Rights Shares”) and 284 warrants, with each warrant representing the right to purchase one share of Common Stock (the “Rights Warrants”), at a subscription price of $1,000 per Unit in cash (the “Subscription Price”).
ATOSSA GENETICS INC. WARRANT AGENCY AGREEMENTWarrant Agency Agreement • April 23rd, 2018 • Atossa Genetics Inc • Pharmaceutical preparations • New York
This WARRANT AGENCY AGREEMENT (this “Warrant Agreement”) dated as of [●], 2018 (the “Issuance Date”), is by and among Atossa Genetics Inc., a Delaware corporation (“Company”) and VStock Transfer, LLC (the “Warrant Agent”). Capitalized terms used in this Warrant Agreement and not otherwise defined herein shall have the respective meanings ascribed to them in the Common Stock Purchase Warrant (as defined below). In the event a capitalized term used herein is defined in both this Warrant Agreement and the Common Stock Purchase Warrant, the meaning given to such term in the Common Stock Purchase Warrant shall control.
